To hear about similar clinical trials, please enter your email below
Trial Title:
WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma
NCT ID:
NCT05925764
Condition:
Lung Adenocarcinoma
Whole Slide Image
IASLC Grading System
Artificial Intelligence
Conditions: Official terms:
Adenocarcinoma
Adenocarcinoma of Lung
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Whole Slide Image based Deep Learning
Description:
Whole Slide Image Based Deep Learning for Diagnosing the IASLC Grading System of Lung
Adenocarcinoma
Summary:
The purpose of this study is to evaluate the performance of a whole slide image based
deep learning model for diagnosing the IASLC grading system in resected lung
adenocarcinoma based on a multicenter prospective cohort.
Criteria for eligibility:
Study pop:
Resected Lung Adenocarcinoma
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Age ranging from 18-85 years old;
2. Pathological confirmation of primary lung adenocarcinoma after surgery;
3. Obtained written informed consent.
Exclusion Criteria:
1. Multiple lung lesions;
2. Poor quality of whole slide images;
3. Mucinous adenocarcinomas and variants;
4. Participants who have received neoadjuvant therapy.
Gender:
All
Minimum age:
18 Years
Maximum age:
85 Years
Locations:
Facility:
Name:
Affiliated Hospital of Zunyi Medical University
Address:
City:
Zunyi
Country:
China
Status:
Recruiting
Contact:
Last name:
Yongxiang Song, Dr
Phone:
15505177258
Email:
zhong961008@163.com
Facility:
Name:
The First Affiliated Hospital of Nanchang University
Address:
City:
Nanchang
Country:
China
Status:
Recruiting
Contact:
Last name:
Bentong Yu, Dr
Phone:
021-65115006
Email:
1151697503@qq.com
Facility:
Name:
Ningbo HwaMei Hospital
Address:
City:
Ningbo
Country:
China
Status:
Recruiting
Contact:
Last name:
Minglei Yang, Dr
Phone:
021-65115006
Email:
almondjj@163.com
Start date:
October 15, 2024
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Shanghai Pulmonary Hospital, Shanghai, China
Agency class:
Other
Source:
Shanghai Pulmonary Hospital, Shanghai, China
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05925764
